FilingIndex
10-KThe Record

Travere Therapeutics, Inc. files 10-K

Filed Mar 1, 2017 · 9y ago · Accession 0001438533-17-000005

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
TVTX
CIK
1438533
Form type
10-K
Filing date
Mar 1, 2017
Report date
Dec 31, 2016
Document
rtrx-20161231x10k.htm
Size
12.6 MB